Medline debuts on Nasdaq after largest IPO of 2025

Shares of U.S. medical provides large Medline jumped greater than 22% of their debut on the Nasdaq on Wednesday after the most important preliminary public providing of the 12 months globally.

The inventory opened at $35, up from its $29 IPO worth.

The personal equity-owned firm offered slightly over 216 million shares on Tuesday, elevating $6.26 billion in an upsized providing that finishes off a powerful 12 months for brand spanking new listings and bolsters optimism in regards to the IPO market in 2026. Shares of Medline will commerce beneath the image “MDLN.” 

That IPO pricing offers Medline a market worth of at the least $37 billion, primarily based on the shares listed in its regulatory filings.

“Traditionally, we have accomplished little or no promoting, little or no advertising, and this offers us a technique to amplify our voice and really develop actually the receptivity of who we’re,” Medline CEO Jim Boyle informed CNBC’s “Squawk Field” earlier Wednesday. “We’re the most important firm you’ve got by no means heard of, and we occur to be all over the place. And that is a very fascinating factor.”

The U.S. IPO market has held regular regardless of market volatility within the spring, pushed by President Donald Trump’s sweeping tariffs, and the longest U.S. authorities shutdown in historical past within the fall. Simply over 200 IPOs have priced this 12 months, together with Medline, which is the most important U.S. itemizing since Rivian‘s $13.7 billion deal in November 2021, in line with knowledge compiled by CNBC.

However Medline’s IPO can be among the many largest personal equity-backed listings. Three personal fairness corporations – Blackstone, Carlyle and Hellman & Friedman – acquired a majority stake within the firm in 2021 for a whopping $34 billion. On the time, the deal was the most important leveraged buyout because the monetary disaster. 

Medline, based in 1966, relies in Northfield, Illinois. The corporate manufactures and distributes roughly 335,000 totally different medical and surgical provides – from gloves, masks and scalpels to wheelchairs. Medline has clients in additional than 100 international locations and, as of the top of 2024, employed greater than 43,000 staff worldwide. 

Medline’s whole debt was round $16.8 billion as of late September 2025. The corporate raked in $25.5 billion in internet gross sales in 2024.

Medline’s earlier plans to go public this 12 months have been postponed on account of uncertainty round tariffs affecting merchandise from Asia. The vast majority of the corporate’s merchandise are sourced or manufactured in Asian nations, significantly China. 

Medline expects a $150 million to $200 million hit from tariffs to earnings earlier than taxes in fiscal 2026.

The corporate competes with names like McKesson and Cardinal Well being. 

— CNBC’s Gina Francolla contributed to this report